key: cord-1034179-17p3my3f
authors: Tanaka, Ryo; Nukui, Takamasa; Haryuni, Ratna Dini; Mori, Makoto; Hayashi, Shigeru; Noguchi, Kyo; Nakatsuji, Yuji
title: Radial linear perivascular emphasis in coronavirus disease 2019‐associated acute disseminated encephalomyelitis
date: 2021-09-03
journal: Clin Exp Neuroimmunol
DOI: 10.1111/cen3.12668
sha: 62327ca9fb6493a60eec38ed23f0d000a0fa9780
doc_id: 1034179
cord_uid: 17p3my3f

A 62‐year‐old woman with coronavirus disease (COVID‐19) developed coma on day 19 after her pneumonia was ameliorated. Brain magnetic resonance imaging with gadolinium showed radial linear perivascular enhancement, typically seen in glial fibrillary acidic protein (GFAP) astrocytopathy, although anti‐GFAP antibody results were negative. Her consciousness recovered with high‐dose steroid administration. We diagnosed the patient with COVID‐19‐associated acute disseminated encephalomyelopathy (ADEM) with radial linear perivascular emphasis.[Image: see text]

A 62-year-old woman who had a history of chronic hepatitis B and hypertension presented to a local hospital with cough and fever, and was admitted on day 3. As her chest computed tomography showed bilateral ground-glass opacities, and severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) saliva polymerase chain reaction was positive, she was diagnosed with coronavirus disease 2019 (COVID-19) pneumonia and was treated with favipiravir. On day 7, she was in a relatively good condition, as she was afebrile with a little cough. However, on day 18, she became comatose, which was followed with convulsive seizures, prompting administration of diazepam and levetiracetam. 

Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis

Encephalitis with radial perivascular emphasis: not necessarily associated with GFAP antibodies

Brain immunohistopathology in a patient with autoimmune glial fibrillary acidic protein astrocytopathy

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

Invited review: the spectrum of neuropathology in COVID-19

• Informed Consent: The patient gave informed consent.